General Announcement::PRESS RELEASE: BIOLIDICS TO DEVELOP ITS PROPRIETARY CANCER DIAGNOSTICS SOLUTIONS IN CHINA
Issuer & Securities
Issuer/ Manager
BIOLIDICS LIMITED
Securities
BIOLIDICS LIMITED - SGXE89830751 - 8YY
Stapled Security
No
Announcement Details
Announcement Title
General Announcement
Date &Time of Broadcast
28-Feb-2020 17:20:28
Status
New
Announcement Sub Title
PRESS RELEASE: BIOLIDICS TO DEVELOP ITS PROPRIETARY CANCER DIAGNOSTICS SOLUTIONS IN CHINA
Announcement Reference
SG200228OTHRGWTL
Submitted By (Co./ Ind. Name)
Yee Pinh Jeremy
Designation
Non-Executive Non-Independent Chairman
Description (Please provide a detailed description of the event in the box below)
Please refer to attachment.
Attachments
Biolidics_lianchuan_collaboration.pdf
Total size =292K
Related Announcements
Related Announcements